DNTH vs HST · rev $6.2M vs P/E 16, rev $5.68B
Dianthus Therapeutics Inc. (DNTH) versus Host Hotels & Resorts Inc (HST) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Host Hotels & Resorts Inc (HST) is a reit - hotel & motel company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported HST revenue for 2024-12-31 was $5.68B. Net income was $707.0M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. HST currently screens at market cap $15.94B and trailing P/E 15.6.
DNTH currently screens at market cap $4.40B. HST currently screens at market cap $15.94B and trailing P/E 15.6.
Not investment advice. Open the DNTH and HST stock pages for the full models.
Not investment advice.